Credit: Getty Images. Although the clinical presentation of acute pancreatitis may vary, the most common symptom occurring in 95% of cases is deep epigastric pain that radiates to the back.

Tris Pharma Showcases a Novel Mechanism of Dual-NOP/MOP (NMR) Agonism for the Treatment of Moderate-to-Severe Acute Pain and Encores Positive Phase 3 Data at 2025 Annual PAINWeek Meeting in Las Vegas ...

An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

Acute pain is sharp, sudden, and short-lived discomfort. It typically lasts only a brief time. Though it may not be serious, it could point to an underlying problem in some cases. Acute pain comes on ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases, particularly acute myocardial infarction, are the leading cause of disability and ...

Clinical trials of a novel non-opioid analgesic have found it to be effective in reducing acute postoperative pain, opening the door to a new way of managing short-term pain that avoids the pitfalls ...

Lower back pain is one of the most common ailments, with four out of five people experiencing it at some point in their lives, according to the website for the Cleveland Clinic in Cleveland, Ohio. For ...

– Positive results from ALLEVIATE-1 Phase 3 pivotal trial for cebranopadol which demonstrates statistically significant pain reduction compared to placebo in patients after abdominoplasty will be ...